Search Results

Keywords: tilray

Feds grant UC San Diego cannabis import license for product from Canada’s Tilray

Published September 18, 2018 | By Omar Sacirbey

In a rare move, the U.S. Drug Enforcement Administration approved the importation of marijuana extracts from Canada for a clinical trial, a decision that paves the way for additional research into the potential medical benefits of cannabis. New research into medical marijuana could persuade more U.S. physicians to recommend the drug, which could provide a boost […]

Cannabis firm Tilray cuts ties with Namaste Technologies following pledge party

Published September 17, 2018 | By Lisa Bernard-Kuhn

A reportedly racy shareholder party hosted by Namaste Technologies has cost the Toronto company its business ties with fast-growing cannabis producer Tilray.

Officials with Tilray confirmed in an email to Marijuana Business Daily that it had “ended its relationship” with Namaste after a highly publicized “pledge party” the firm held for stockholders who promised not to sell company shares for 90 days.

Cannabis stocks: Tilray’s shares jump more than 30% in Nasdaq debut

Published July 19, 2018

Canadian medical marijuana producer Tilray stock surged 32% on its first day of trading on the Nasdaq, a signal of a bullish stance towards the cannabis industry.

Cannabis stocks: What you need to know about Tilray’s IPO on the Nasdaq

Published July 19, 2018 | By Lisa Bernard-Kuhn

Canadian medical marijuana company Tilray began trading on the Nasdaq on Thursday, making it the first cannabis business to go public on a major U.S. exchange via an initial public offering (IPO). One of the larger cannabis companies in Canada, Tilray plans to list on the Nasdaq Global Select Market under the ticker symbol TLRY. […]

Cannabis firm Tilray outlines IPO terms ahead of listing on Nasdaq

Published July 9, 2018 | By Lisa Bernard-Kuhn

Tilray, a Canadian marijuana company owned by Seattle private equity firm Privateer Holdings, unveiled the terms of a previously announced initial public offering. The British Columbia-based company, which filed for the IPO last month, plans to issue 9 million shares of its common stock priced between $14 and $16 (CA$18.40 and CA$21) a share. The IPO […]

Canadian cannabis company Tilray files for IPO, eyes Nasdaq listing

Published June 20, 2018

Tilray, the British Columbia cannabis company owned by Seattle private equity firm Privateer, filed paperwork with the U.S. Securities and Exchange Commission on Wednesday to go public. The vertically integrated grow, processing and distribution company – one of the bigger cannabis companies in Canada – intends to list on the Nasdaq Global Select Market under […]

Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray

Published March 19, 2018

British Columbia-based medical marijuana producer Tilray announced Monday it has formed a strategic partnership with Sandoz Canada, the first known affiliation between a marijuana producer and a major pharmaceutical company. Tilray signed a letter of intent with the Quebec-based affiliate of Sandoz International GmbH, an arm of global health care giant Novartis. The entry of […]

Tilray raises CA$60M to sharply boost global cannabis production

Published February 8, 2018 | By Matt Lamers

Tilray said it raised 60 million Canadian dollars ($47 million) in financing that will allow the licensed producer to ramp up marijuana production capacity nearly fivefold this year to meet demand in Europe and Canada’s rapidly expanding medical cannabis markets. The additional money puts Tilray in a position to increase annual capacity in Canada and Portugal […]

Tilray signs medical cannabis supply deal with Canada’s Shoppers Drug Mart

Published January 19, 2018 | By Matt Lamers

The largest pharmacy chain in Canada locked up another major supplier of medical marijuana, as drugstore chains across the country look to secure supply from a limited number of producers. Shoppers Drug Mart will carry Tilray-branded medical cannabis products for sale nationwide through its online store, including whole flower, oil and capsules. The products will […]

Tilray exports medical cannabis to New Zealand for national dispersal

Published October 2, 2017

Tilray has started supplying medical marijuana to the New Zealand market for nationwide distribution, filling the nation’s cannabis supply shortfall two weeks after its government lifted restrictions on cannabidiol. British Columbia-based Tilray’s medical marijuana will be available in pharmacies across New Zealand, the company said in a news release. The Ministry of Health’s liberalized rules on cannabidiol went […]

Canada’s Tilray to spend $24M to build marijuana facility in Portugal

Published September 7, 2017 | By Matt Lamers

Tilray plans to spend 20 million euros ($24 million) to build a medical marijuana production facility in Portugal to serve the European Union, becoming the second Canadian licensed producer to unveil plans to build an overseas cultivation operation for exporting MMJ.

Canada needs to expand recreational marijuana products: Q&A with Tilray CEO Brendan Kennedy

Published August 31, 2017

By Matt Lamers The CEO of one of Canada’s fast-growing marijuana companies has a piece of advice for the federal government: Permit a wider variety of products beyond buds and oils when the recreational market launches next year.